Variant report
Variant | nsv979893 |
---|---|
Chromosome Location | chr3:157523985-157526573 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6768254 | chr3:157524027-157524028 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs34345789 | chr3:157524055-157524056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527353171 | chr3:157524077-157524078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542847562 | chr3:157524092-157524093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560882543 | chr3:157524093-157524094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531674385 | chr3:157524122-157524123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549805523 | chr3:157524172-157524173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531385497 | chr3:157524814-157524815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543731648 | chr3:157524826-157524827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs150420862 | chr3:157524847-157524848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs75896011 | chr3:157524875-157524876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs386667450 | chr3:157524886-157524887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs78459146 | chr3:157524887-157524888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188818830 | chr3:157524907-157524908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs3914481 | chr3:157524952-157524953 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs567875409 | chr3:157524962-157524963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538072526 | chr3:157524973-157524974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs34023008 | chr3:157524982-157524983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs77915410 | chr3:157525007-157525008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs571852256 | chr3:157525009-157525010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs80227592 | chr3:157525037-157525038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558725855 | chr3:157525040-157525041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377442721 | chr3:157525062-157525063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs138339499 | chr3:157525063-157525064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs369850986 | chr3:157525118-157525119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs553846179 | chr3:157525124-157525125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181244228 | chr3:157525132-157525133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142878906 | chr3:157525168-157525169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115652507 | chr3:157525179-157525180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs373006897 | chr3:157525190-157525191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144969225 | chr3:157525221-157525222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs111802238 | chr3:157525322-157525323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs80053152 | chr3:157525360-157525361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs77194349 | chr3:157525394-157525395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs186181512 | chr3:157525408-157525409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191037521 | chr3:157525415-157525416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs540916049 | chr3:157525436-157525437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560160259 | chr3:157525449-157525450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs138833505 | chr3:157525462-157525463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181053014 | chr3:157525518-157525519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186046059 | chr3:157525524-157525525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546395663 | chr3:157525552-157525553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs532151327 | chr3:157525588-157525589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs191167543 | chr3:157525596-157525597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571863423 | chr3:157525658-157525659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539389506 | chr3:157525740-157525741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs548090967 | chr3:157525907-157525908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565716228 | chr3:157525942-157525943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs536266391 | chr3:157525963-157525964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs554517933 | chr3:157525996-157525997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21509527 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:157522200-157524200 | Enhancers | Fetal Intestine Large | intestine |
2 | chr3:157523000-157524000 | Enhancers | Liver | Liver |
3 | chr3:157524800-157525200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
4 | chr3:157524800-157525600 | Enhancers | NHDF-Ad | bronchial |
5 | chr3:157524800-157525800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr3:157525800-157529200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |